Content Library

Explore how early integration of toxicologic pathology can improve medical device safety, reduce miscommunication, and strengthen regulatory outcomes in device development.

Learn how integrating toxicologic pathology best practices into medical device evaluation can improve biological assessment, strengthen regulatory outcomes, and reduce study risk.

As part of the World Health Organization (WHO), the International Agency for Research on Cancer (IARC) works to identify potential carcinogenic hazards to humans.

Intravitreal drug development is challenging, primarily due to the sensitivity of the eye and the limited safe injection volume.

Traditional diagnostic pathology relies on a narrowly scoped set of expertise and technologies to identify and diagnose diseases and determine treatment efficacy based on tissue examination.

Mass Spectrometry Imaging (MSI) measures in tissue sections at microscopic resolution the mass-to-charge ratio of ions via an analytical technique that makes the identification of different molecular species possible.

When it comes to neuropathology studies, there is no one-size-fits-all approach.

Discover Dr. Quinci Plumlee's collaboration on the male rat's reproductive system in "Toxicologic Pathology, A Primer".

While the Marburg virus disease (MVD) is deadly to humans, the filovirus responsible for it—i.e., the Marburg virus (MARV)—is carried asymptotically in Egyptian rousette bats (ERBs).

Products such as cytotoxic chemotherapeutics and AAV-based gene therapies are associated with gangliotoxicity. Despite this, prior toxicology guidance provided no recommendations for which sensory and autonomic ganglia to evaluate in nonclinical general toxicity studies.

Good Laboratory Practices (GLP) refers to a system where non-clinical health and safety studies are carried out, planned, monitored, recorded, archived and reported.